3:45 pm Panel Discussion: Expanding GLP1’s Role to Target MASH-Related Comorbidities to Improve Holistic Patient Outcomes
Time: 3:45 pm
day: Conf day 2
Details:
- Detailing GLP-1s effects on comorbidities to illustrate how these drugs can address a range of MASH-related comorbidities to offer a comprehensive treatment strategy to improve overall patient management
- Highlighting the benefits of a holistic approach to understand the advantages of using GLP-1s to manage MASH and its associated conditions to lead to better coordination of care and a more integrated approach to treatment
- Emphasizing improved patient outcomes to lead to better overall health and well-being for MASH patients to reduce the burden of multiple diseases, and improve their long-term prognosis
